Özlem Nuray Sever
-
- Cancer Immunotherapy and Biomarkers 9
- Inflammatory Biomarkers in Disease Prognosis 6
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 3
-
- Breast Cancer Treatment Studies 4
- Protease and Inhibitor Mechanisms 3
-
- Renal cell carcinoma treatment 8
- Lung Cancer Treatments and Mutations 4
Özlem Nuray Sever
32 papers receiving 276 citations
Peers
Comparison fields: 5 of 53
- Oncology 204
- Cancer Research 92
- Radiology, Nuclear Medicine and Imaging 61
- Surgery 87
- Pulmonary and Respiratory Medicine 51
Countries citing papers authored by Özlem Nuray Sever
This map shows the geographic impact of Özlem Nuray Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Nuray Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Nuray Sever more than expected).
Fields of papers citing papers by Özlem Nuray Sever
This network shows the impact of papers produced by Özlem Nuray Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Nuray Sever. The network helps show where Özlem Nuray Sever may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Özlem Nuray Sever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 30 | |
| 14 | 2022 | 3 | |
| 15 | 2021 | 51 | |
| 16 | 2021 | 72 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 2 | |
| 19 | 2020 | 6 | |
| 20 | 2011 | 8 |
About Özlem Nuray Sever
Özlem Nuray Sever is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 278 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Renal cell carcinoma treatment (8 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Breast Cancer Treatment Studies (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Oncology (204 citations), Cancer Research (92 citations) and Radiology, Nuclear Medicine and Imaging (61 citations). Özlem Nuray Sever has collaborated with scholars based in Türkiye, India and Antigua and Barbuda. Frequent co-authors include Ertan Şahin, Umut Elboğa, Y. Zeki Çelen, Osman Demir, Fatih Teker, Havva Yeşil Çınkır, Benan Kılbaş, Aydın Aytekin, Gökmen Aktaş and Tülay Kuş. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports, Journal of Clinical Medicine, Clinical & Translational Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.